…only the state of Minnesota could figure out a way to lose money selling drugs.
But they pulled it off:
The state’s manufacturers combined to lose more than $5 million in the first year of legal medical marijuana sales in 2015. And patient count hasn’t met projections, exacerbating high prescription costs for patients that the two companies who cultivate and sell medication have only recently begun to address with modest price decreases.
The Office of Medical Cannabis’ request for more than $500,000 over the next two years is just a fraction of the $40 billion-plus budget Minnesota’s Legislature will assemble this year.
But state regulators say that money is critical to cover the higher-than-expected costs for maintenance of their around-the-clock patient registry and the costs of performing 120 inspections or more each year.
Of course it does.
Leave a Reply
You must be logged in to post a comment.